Home/Filings/4/0001209191-18-046026
4//SEC Filing

Leverone Jason A. 4

Accession 0001209191-18-046026

CIK 0001590750other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 4:18 PM ET

Size

7.2 KB

Accession

0001209191-18-046026

Insider Transaction Report

Form 4
Period: 2018-08-07
Leverone Jason A.
CFO, Treasurer & Secretary
Transactions
  • Exercise/Conversion

    Common Stock

    2018-08-07$0.57/sh+29,530$16,83230,737 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-08-0729,5300 total
    Exercise: $0.57Exp: 2018-12-09Common Stock (29,530 underlying)
Footnotes (1)
  • [F1]The option is fully vested and exercisable. The option expires ten years after the date of grant.

Issuer

MIRAGEN THERAPEUTICS, INC.

CIK 0001590750

Entity typeother

Related Parties

1
  • filerCIK 0001692747

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:18 PM ET
Size
7.2 KB